The National Institutes of Health today unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients. NIH’s new National Center for Advancing Translational Sciences (NCATS) has partnered initially with Pfizer, AstraZeneca, and Eli Lilly and Company which have agreed to make dozens…
Bill Would Expedite FDA Approval and Increase Clinical Trial Flexibility of Drugs and Treatments That Show Dramatic Early Responses – Washington, DC – Senators Michael Bennet (D-CO), Orrin Hatch (R-UT) and Richard Burr (R-NC) today introduced a bipartisan bill to help bring breakthrough drugs and treatments to patients who need them more quickly. The Advancing…
The SSO Recognized Paulsen for Her Leadership of the Entertainment Industry Foundation, Including Her Efforts in the Creation of the “Stand Up To Cancer” Initiative – Los Angeles, CA – March 23, 2012 – The Society of Surgical Oncology (SSO) and its James Ewing Foundation recognized the efforts of Stand Up to Cancer’s co-founder Lisa…
The U.S. Food and Drug Administration has completed its recommendations for three user fee programs that will help speed safe and effective drugs and lower-cost generic drug and biosimilar biological products to patients, FDA Commissioner Margaret A. Hamburg, M.D. said today. The recommendations were transmitted to Congress today by Health and Human Services Secretary Kathleen Sebelius.…
HEALTH AFFAIRS STUDY
HEALTH AFFAIRS STUDY
WASHINGTON, D.C., Oct 28, 2011 (BUSINESS WIRE) – Susan G. Komen for the Cure(R) tonight paid tribute to global leaders in the fight against breast cancer, including the late Betty Ford, at a star-studded event at the John F. Kennedy Center for the Performing Arts for the second annual “Honoring the Promise” gala. Breast cancer…
Friends of Cancer Research Video Narrated by Oscar-Winning Actor and Cancer Survivor Michael Douglas
Friends of Cancer Research Video Narrated by Oscar-Winning Actor and Cancer Survivor Michael Douglas
Click Here to Read Statement
